Emergency Department, Erasmus Medical Center.
Department of Anesthesiology, Maasstad Hospital.
Eur J Emerg Med. 2024 Apr 1;31(2):118-126. doi: 10.1097/MEJ.0000000000001092. Epub 2023 Oct 6.
Sudden cardiac arrest has a high incidence and often leads to death. A treatment option that might improve the outcomes in refractory cardiac arrest is Extracorporeal Cardiopulmonary Resuscitation (ECPR).
This study investigates the number of in-hospital cardiac arrest (IHCA) and out-of-hospital cardiac arrest (OHCA) patients eligible to ECPR and identifies clinical characteristics that may help to identify which patients benefit the most from ECPR.
DESIGN, SETTINGS AND PARTICIPANTS: A retrospective two-centre study was conducted in Rotterdam, the Netherlands. All IHCA and OHCA patients between 1 January 2017 and 1 January 2020 were screened for eligibility to ECPR. The primary outcome was the percentage of patients eligible to ECPR and patients treated with ECPR. The secondary outcome was the comparison of the clinical characteristics and outcomes of patients eligible to ECPR treated with conventional Cardiopulmonary Resuscitation (CCPR) vs. those of patients treated with ECPR.
Out of 1246 included patients, 412 were IHCA patients and 834 were OHCA patients. Of the IHCA patients, 41 (10.0%) were eligible to ECPR, of whom 20 (48.8%) patients were actually treated with ECPR. Of the OHCA patients, 83 (9.6%) were eligible to ECPR, of whom 23 (27.7%) were actually treated with ECPR. In the group IHCA patients eligible to ECPR, no statistically significant difference in survival was found between patients treated with CCPR and patients treated with ECPR (hospital survival 19.0% vs. 15.0% respectively, 4.0% survival difference 95% confidence interval -21.3 to 28.7%). In the group OHCA patients eligible to ECPR, no statistically significant difference in-hospital survival was found between patients treated with CCPR and patients treated with ECPR (13.3% vs. 21.7% respectively, 8.4% survival difference 95% confidence interval -30.3 to 10.2%).
This retrospective study shows that around 10% of cardiac arrest patients are eligible to ECPR. Less than half of these patients eligible to ECPR were actually treated with ECPR in both IHCA and OHCA.
心脏骤停发病率高,常导致死亡。体外心肺复苏(ECPR)可能是一种改善难治性心脏骤停患者预后的治疗选择。
本研究调查了符合 ECPR 条件的院内心脏骤停(IHCA)和院外心脏骤停(OHCA)患者数量,并确定了可能有助于确定哪些患者最受益于 ECPR 的临床特征。
设计、地点和参与者:本研究在荷兰鹿特丹的两个中心进行了回顾性研究。对 2017 年 1 月 1 日至 2020 年 1 月 1 日期间所有 IHCA 和 OHCA 患者进行了 ECPR 资格筛选。主要结局是符合 ECPR 条件的患者比例和接受 ECPR 治疗的患者比例。次要结局是比较符合 ECPR 条件的患者接受常规心肺复苏(CCPR)治疗与接受 ECPR 治疗的患者的临床特征和结局。
在纳入的 1246 名患者中,412 名患者为 IHCA 患者,834 名患者为 OHCA 患者。在 IHCA 患者中,有 41 名(10.0%)符合 ECPR 条件,其中 20 名(48.8%)患者实际接受了 ECPR 治疗。在 OHCA 患者中,有 83 名(9.6%)符合 ECPR 条件,其中 23 名(27.7%)患者实际接受了 ECPR 治疗。在符合 ECPR 条件的 IHCA 患者中,接受 CCPR 治疗与接受 ECPR 治疗的患者的生存率无统计学差异(院内生存率分别为 19.0%和 15.0%,4.0%的生存率差异 95%置信区间-21.3 至 28.7%)。在符合 ECPR 条件的 OHCA 患者中,接受 CCPR 治疗与接受 ECPR 治疗的患者的院内生存率无统计学差异(分别为 13.3%和 21.7%,8.4%的生存率差异 95%置信区间-30.3 至 10.2%)。
本回顾性研究表明,约 10%的心脏骤停患者符合 ECPR 条件。在 IHCA 和 OHCA 中,符合 ECPR 条件的患者中,不到一半的患者实际接受了 ECPR 治疗。